NCT01511900 - A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Type 2 Diabetes

Interventions

DRUG

CAT 1004

Multiple dose oral administration once daily for 14 days of CAT 1004 at dose level 1-9 subjects will be treated with CAT-1004

DRUG

Placebo

Multiple dose oral administration of placebo daily for 14 days-3 subjects will be treated with placebo per cohort

DRUG

CAT 1004

Multiple dose oral administration once daily for 14 days of CAT 1004 at dose level 2 -9 subjects will be treated with CAT-1004

DRUG

CAT 1004

Multiple dose oral administration BID for 14 days of CAT 1004 at dose level 3-9 subjects will be treated with CAT-1004

DRUG

CAT 1004

Multiple dose oral administration BID for 14 days of CAT 1004 at dose level 4-9 subjects will be treated with CAT-1004

DRUG

CAT 1004

Multiple dose oral administration daily for 14 days of CAT 1004 at dose level TBD-9 subjects will be treated with CAT-1004

Trial Locations (1)

Chula Vista